A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis

NCT02757352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondyloarthritis

Interventions

DRUG: Ixekizumab
DRUG: Placebo

Sponsor

Eli Lilly and Company